| EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease A Berardelli, GK Wenning, A Antonini, D Berg, BR Bloem, V Bonifati, ... European journal of neurology 20 (1), 16-34, 2013 | 624 | 2013 |
| Levodopa‐induced dyskinesias G Fabbrini, JM Brotchie, F Grandas, M Nomoto, CG Goetz Movement disorders: official journal of the Movement Disorder Society 22 (10 …, 2007 | 567 | 2007 |
| Levodopa in the treatment of Parkinson's disease: current controversies CW Olanow, Y Agid, Y Mizuno, A Albanese, U Bonucelli, P Damier, ... Movement disorders 19 (9), 997-1005, 2004 | 503 | 2004 |
| Blepharospasm: a review of 264 patients. F Grandas, J Elston, N Quinn, CD Marsden Journal of Neurology, Neurosurgery & Psychiatry 51 (6), 767-772, 1988 | 440 | 1988 |
| Motor complications associated with chronic levodopa therapy in Parkinson's disease. JA Obeso, F Grandas, J Vaamonde, MR Luquin, J Artieda, G Lera, ... Neurology 39 (11 Suppl 2), 11-19, 1989 | 201 | 1989 |
| Risk factors for levodopa-induced dyskinesias in Parkinson’s disease F Grandas, ML Galiano, C Tabernero Journal of neurology 246, 1127-1133, 1999 | 188 | 1999 |
| IMU-based classification of Parkinson's disease from gait: A sensitivity analysis on sensor location and feature selection C Caramia, D Torricelli, M Schmid, A Munoz-Gonzalez, ... IEEE journal of biomedical and health informatics 22 (6), 1765-1774, 2018 | 182 | 2018 |
| Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery T Müller, T van Laar, DR Cornblath, P Odin, F Klostermann, FJ Grandas, ... Parkinsonism & related disorders 19 (5), 501-507, 2013 | 117 | 2013 |
| Risk of falls in Parkinson’s disease: a cross-sectional study of 160 patients A Contreras, F Grandas Parkinson’s Disease 2012, 2012 | 108 | 2012 |
| The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease JA Obeso, F Grandas, MT Herrero, R Horowski European Journal of Neuroscience 6 (6), 889-897, 1994 | 104 | 1994 |
| Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial GU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ... The Lancet Neurology 20 (3), 182-192, 2021 | 102 | 2021 |
| Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study F Valldeoriola, I Regidor, A Mínguez-Castellanos, E Lezcano, ... Journal of Neurology, Neurosurgery & Psychiatry 81 (1), 65-69, 2010 | 99 | 2010 |
| Acquired hepatocerebral degeneration: clinical characteristics and MRI findings R Fernandez‐Rodriguez, A Contreras, JG De Villoria, F Grandas European journal of neurology 17 (12), 1463-1470, 2010 | 93 | 2010 |
| The significance of ophthalmological symptoms in idiopathic blepharospasm JS Elsron, CD Marsden, F Grandas, NP Quinn Eye 2 (4), 435-439, 1988 | 90 | 1988 |
| Risk factors for freezing of gait in Parkinson's disease A Contreras, F Grandas Journal of the neurological sciences 320 (1-2), 66-71, 2012 | 81 | 2012 |
| Clinical and CT scan findings in a case of cyanide intoxication F Grandas, J Artieda, JA Obeso Movement disorders 4 (2), 188-193, 1989 | 67 | 1989 |
| Nocturnal problems occurring in Parkinson’s disease F Grandas, A Iranzo Neurology 63 (8_suppl_3), S8-S11, 2004 | 62 | 2004 |
| Parkinsonism and spastic paraplegia type 7: expanding the spectrum of mitochondrial Parkinsonism B De la Casa‐Fages, G Fernández‐Eulate, J Gamez, ... Movement Disorders 34 (10), 1547-1561, 2019 | 56 | 2019 |
| Apomorphine infusion for motor fluctuations in Parkinson's disease JA Obeso, F Grandas, J Vaamonde, MR Luquin, JM Martínez-Lage The Lancet 329 (8546), 1376-1377, 1987 | 55 | 1987 |
| Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson’s disease: a systematic review M Steiger, W Jost, F Grandas, G Van Camp Journal of neural transmission 116, 179-191, 2009 | 54 | 2009 |
